- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02287545
Biomechanical Changes After Trabeculectomy (TE-biomech)
August 20, 2015 updated by: Dr. Karin Pillunat, Technische Universität Dresden
Corneal Biomechanical Changes Following Trabeculectomy
Corneal biomechanics are studied in glaucoma patients prior and at least 6 month after trabeculectomy.
Study Overview
Detailed Description
Prior to trabeculectomy corneal biomechanics are measured with the Ocular Response Analyzer (ORA, Reichert) and the Corvis st (Oculus).
Both instruments work with an air-puff which deforms the cornea.
Intraocular pressure is measured like in non-contact air-puff tonometry.
The ORA also measures corneal hysteresis (CH) and the corneal resistance factor (CRF) which are qualitative measures of corneal biomechanics.
The Corvis is a high-speed Scheimpflug-camera (4330 frames/sec) that records the quantitative movements of the cornea.
At least 6 month after uncomplicated trabeculectomy the measurements are repeated.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saxony
-
Dresden, Saxony, Germany, 01307
- Technical University Dresden
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Primary open-angle glaucoma patients assigened for a trabeculectomy.
Description
Inclusion Criteria:
- Glaucoma patients in need of further IOP-reduction despite maximally tolerated therapy and assigned for trabeculectomy. Minimum of 18 years.
Exclusion Criteria:
- Corneal pathologies.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Glaucoma, primary
Glaucoma patients undergoing trabeculectomy
|
Standard trabeculectomy with the use of antimetabolites (mitomycin C) for glaucoma patients with insufficient intraocular pressure (IOP) control taking maximally tolerated IOP-reducing medication, visual field progression despite maximally tolerated IOP-reducing medication, adverse events because of maximally tolerated IOP-reducing medication or nono.compliance.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Corneal biomechanical changes following trabeculectomy
Time Frame: 2-3 years
|
Evaluation of biomechanical properties of the cornea before and after trabeculectomy to evaluate whether intraocular pressure is accurately measured after trabeculectomy.
Corneal hysteresis and corneal resistance factor as measured with the Ocular Response Analyzer and the corneal deformation response to an air-puff as measured with an ultra-high-speed Scheimpflug camera are assessed.
|
2-3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intraocular pressure after trabeculectomy
Time Frame: 2-3 years
|
Intraocular pressure is measured with 3 different devices (Goldmann applanation tonometry, Ocular Response Analyzer, Corvis st) prior and at least 6 month after trabeculectomy.
|
2-3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karin R Pillunat, MD, Technische Universitat Dresden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
February 1, 2015
Study Completion (Actual)
February 1, 2015
Study Registration Dates
First Submitted
November 4, 2014
First Submitted That Met QC Criteria
November 6, 2014
First Posted (Estimate)
November 10, 2014
Study Record Updates
Last Update Posted (Estimate)
August 21, 2015
Last Update Submitted That Met QC Criteria
August 20, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK399122012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma, Primary
-
Omar SaidCompletedGlaucoma,Primary Open-Angle ,Primary Angle ClosureEgypt
-
Khoo Teck Puat HospitalCompletedPrimary Angle-Closure Glaucoma | Primary Angle Closure Without Glaucoma DamageSingapore
-
Santen Pharma Malaysia Sdn BhdUnknownOcular Hypertension | Primary Open-angle Glaucoma | Pseudoexfoliation Glaucoma | Pigment Dispersion Glaucoma | Primary Angle-Closure Glaucoma
-
Peking UniversityRecruitingPrimary Open Angle Glaucoma | Ocular Hypertension | Primary Open Angle Glaucoma of Both Eyes | Primary Open-Angle Glaucoma, Unspecified Eye | Suspect GlaucomaChina
-
Qlaris Bio, Inc.RecruitingPrimary Open Angle Glaucoma of Both Eyes | Primary Open Angle Glaucoma (POAG) | Primary Open-Angle Glaucoma, Unspecified Eye | Ocular Hypertension (OHT)United States
-
Glaucot Teknoloji Anonim SirketiRecruitingPrimary Open-Angle GlaucomaTurkey
-
China Medical University HospitalCompletedEffect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle GlaucomaPrimary Open-angle GlaucomaTaiwan
-
InnFocus Inc.CompletedPrimary Open-angle GlaucomaSpain, United States, United Kingdom, France, Italy
-
Glaukos CorporationTerminatedPrimary Open-Angle GlaucomaUnited States
-
Rehab mahmoud abdelhamid mohamedCairo UniversityCompletedPrimary Open-angle GlaucomaEgypt
Clinical Trials on trabeculectomy
-
Sunnybrook Health Sciences CentreCompletedGlaucoma | Corneal Endothelial Cell LossCanada
-
Shanghai Eye Disease Prevention and Treatment CenterUnknown
-
University of OklahomaCompletedPrimary Open Angle Glaucoma | Cataract | Pigmentary GlaucomaUnited States
-
University of ZurichCompleted
-
Assiut UniversityUnknownGlaucoma | Angle Closure Glaucoma | Cataract SecondaryEgypt
-
Queen's UniversityGlaucoma Research & Education GroupWithdrawn
-
Helsinki University Central HospitalRecruitingNormal Tension GlaucomaFinland
-
University of California, San FranciscoSeva Foundation; Lumbini Eye Institute and HospitalUnknown